日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Updated Viloxazine Pharmacology: Experiments Establish Norepinephrine Transporter Occupancy and Serotonin 5-HT(2C), 5-HT(2B), and 5-HT(7) Receptor Binding at Therapeutically Relevant Concentrations

维洛沙嗪药理学最新进展:实验证实,在治疗相关浓度下,维洛沙嗪可占据去甲肾上腺素转运体并与血清素 5-HT(2C)、5-HT(2B) 和 5-HT(7) 受体结合。

Garcia-Olivares, Jennie; Yegla, Brittney; Koch, Jennifer; Yu, Chungping; Rubin, Jonathan

Huperzine A suppresses absence seizures in the genetic absence epilepsy rat from Strasbourg (GAERS) model of genetic generalized epilepsy with absence seizures

石杉碱甲可抑制斯特拉斯堡遗传性失神性癫痫大鼠 (GAERS) 的失神性癫痫发作,该模型为伴有失神性癫痫的遗传性全身性癫痫

Pablo M Casillas-Espinosa, Jennie Garcia-Olivares, Rui Li, Crystal Li, Chungping Yu, Andrea E Formella, Terence J O'Brien

Viloxazine Increases Extracellular Concentrations of Norepinephrine, Dopamine, and Serotonin in the Rat Prefrontal Cortex at Doses Relevant for the Treatment of Attention-Deficit/Hyperactivity Disorder

维洛沙嗪在治疗注意力缺陷/多动障碍的相关剂量下,可增加大鼠前额叶皮层中去甲肾上腺素、多巴胺和血清素的细胞外浓度。

Garcia-Olivares, Jennie; Yegla, Brittney; Bymaster, Frank P; Earnest, Jami; Koch, Jennifer; Yu, Chungping; Rubin, Jonathan

Viloxazine in the Management of CNS Disorders: A Historical Overview and Current Status

维洛沙嗪在中枢神经系统疾病治疗中的应用:历史回顾与现状

Findling, Robert L; Candler, Shawn A; Nasser, Azmi F; Schwabe, Stefan; Yu, Chungping; Garcia-Olivares, Jennie; O'Neal, Welton; Newcorn, Jeffrey H

New Insights into the Mechanism of Action of Viloxazine: Serotonin and Norepinephrine Modulating Properties

维洛沙嗪作用机制的新见解:其对血清素和去甲肾上腺素的调节作用

Yu, Chungping; Garcia-Olivares, Jennie; Candler, Shawn; Schwabe, Stefan; Maletic, Vladimir

In vitro pharmacological characterization of SPN-810M (molindone)

SPN-810M(莫林酮)的体外药理学特性

Yu, Chungping; Gopalakrishnan, Gopakumar